Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets.

PubWeight™: 1.97‹?› | Rank: Top 2%

🔗 View Article (PMC 20416)

Published in Proc Natl Acad Sci U S A on May 12, 1998

Authors

A S Weyrich1, D A Dixon, R Pabla, M R Elstad, T M McIntyre, S M Prescott, G A Zimmerman

Author Affiliations

1: Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT 84112, USA. andrew_weyrich@gatormail.cvrti.utah.edu

Articles citing this

Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell (2005) 4.02

Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol (2001) 2.75

Platelets as cellular effectors of inflammation in vascular diseases. Circ Res (2013) 2.62

Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med (2006) 2.39

Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. Blood (2011) 2.38

Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol (2009) 2.26

Anucleate platelets generate progeny. Blood (2010) 2.24

Class prediction models of thrombocytosis using genetic biomarkers. Blood (2009) 1.92

Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol (2008) 1.47

Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol (2013) 1.46

Circular RNA enrichment in platelets is a signature of transcriptome degradation. Blood (2015) 1.45

S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation. Blood (2011) 1.39

mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Blood (2006) 1.39

Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost (2008) 1.38

Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol (2008) 1.38

Neutrophils alter the inflammatory milieu by signal-dependent translation of constitutive messenger RNAs. Proc Natl Acad Sci U S A (2004) 1.27

Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol (2011) 1.26

Platelet genomics and proteomics in human health and disease. J Clin Invest (2005) 1.24

Lipopolysaccharide is a direct agonist for platelet RNA splicing. J Immunol (2008) 1.24

Lnk regulates integrin alphaIIbbeta3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo. J Clin Invest (2009) 1.22

Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets. J Cell Biol (1999) 1.21

Platelets and megakaryocytes contain functional nuclear factor-kappaB. Arterioscler Thromb Vasc Biol (2009) 1.13

Activated polymorphonuclear leukocytes rapidly synthesize retinoic acid receptor-alpha: a mechanism for translational control of transcriptional events. J Exp Med (2004) 1.13

Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes. Proc Natl Acad Sci U S A (2001) 1.12

Platelet-derived S100 family member myeloid-related protein-14 regulates thrombosis. J Clin Invest (2014) 1.06

Proteomic approaches to dissect platelet function: Half the story. Blood (2006) 1.05

Platelet signaling. Handb Exp Pharmacol (2012) 0.99

Sepsis alters the megakaryocyte-platelet transcriptional axis resulting in granzyme B-mediated lymphotoxicity. Am J Respir Crit Care Med (2009) 0.97

Translation control: a multifaceted regulator of inflammatory response. J Immunol (2010) 0.95

TAILS N-terminomics of human platelets reveals pervasive metalloproteinase-dependent proteolytic processing in storage. Blood (2014) 0.95

Platelet mRNA: the meaning behind the message. Curr Opin Hematol (2012) 0.93

Signaling-mediated functional activation of inducible nitric-oxide synthase and its role in stimulating platelet activation. J Biol Chem (2008) 0.92

Translational control in endothelial cells. J Vasc Surg (2007) 0.88

Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50. J Biol Chem (2014) 0.85

The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects. PPAR Res (2008) 0.85

Platelet transfusion - the new immunology of an old therapy. Front Immunol (2015) 0.84

Platelets as central mediators of systemic inflammatory responses. Thromb Res (2010) 0.84

Systematic analysis of microRNA fingerprints in thrombocythemic platelets using integrated platforms. Blood (2012) 0.84

Dynamic Regulation of a Ribosome Rescue Pathway in Erythroid Cells and Platelets. Cell Rep (2016) 0.83

Platelets and Their Interactions with Other Immune Cells. Compr Physiol (2015) 0.83

Intramural delivery of Sirolimus prevents vascular remodeling following balloon injury. Biochim Biophys Acta (2006) 0.83

Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function. Platelets (2014) 0.81

Regulation of the mTOR-Rac1 axis in platelet function. Small GTPases (2012) 0.80

Differential Expression Analysis by RNA-Seq Reveals Perturbations in the Platelet mRNA Transcriptome Triggered by Pathogen Reduction Systems. PLoS One (2015) 0.79

Staphylococcus aureus α-toxin triggers the synthesis of B-cell lymphoma 3 by human platelets. Toxins (Basel) (2011) 0.79

Transgenic Bcl-3 slows T cell proliferation. Int Immunol (2009) 0.79

Sirolimus-eluting stents for percutaneous coronary intervention in acute myocardial infarction Lesson from a case-controlled comparison of bare metal versus drug-eluting stents in thrombus-laden lesions. Z Kardiol (2004) 0.79

Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development. Arterioscler Thromb Vasc Biol (2010) 0.78

Abundance- and Activity-Based Proteomics in Platelet Biology. Curr Proteomics (2011) 0.78

Slowed decay of mRNAs enhances platelet specific translation. Blood (2017) 0.78

A sticky story for signal transducer and activator of transcription 3 in platelets. Circulation (2012) 0.77

Translational control of JunB, an AP-1 transcription factor, in activated human endothelial cells. J Cell Biochem (2013) 0.77

Inducing mitophagy in diabetic platelets protects against severe oxidative stress. EMBO Mol Med (2016) 0.77

Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets. J Thromb Haemost (2014) 0.76

Morphology of platelet Golgi apparatus and their significance after acute cerebral infarction. Neural Regen Res (2013) 0.75

Cancer and Thrombosis: The Platelet Perspective. Front Cell Dev Biol (2017) 0.75

In Vitro and Ex Vivo Approaches to Evaluate Next-Generation Tobacco and Non-Tobacco Products on Human Blood Platelets. Appl In Vitro Toxicol (2017) 0.75

Coming safely to a stop: a review of platelet activity after cessation of antiplatelet drugs. Ther Adv Drug Saf (2015) 0.75

Genetic dissection of platelet function in health and disease using systems biology. Hematol Oncol Clin North Am (2013) 0.75

New frontiers for platelet CD154. Exp Hematol Oncol (2015) 0.75

Biomarkers and Bioassays for Cardiovascular Diseases: Present and Future. Biomark Insights (2008) 0.75

Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study. Intensive Care Med Exp (2017) 0.75

Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance. Haematologica (2017) 0.75

Articles cited by this

An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol (1991) 12.00

Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature (1995) 7.05

PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science (1994) 5.62

Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell (1996) 5.12

PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science (1995) 4.51

The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell (1990) 3.41

A signaling pathway to translational control. Cell (1996) 3.29

Molecular mechanisms of platelet activation. Physiol Rev (1989) 3.22

Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest (1996) 2.51

The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Curr Opin Cell Biol (1995) 2.09

Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest (1995) 2.06

Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. J Biol Chem (1993) 1.81

Outside-in integrin signal transduction. Alpha IIb beta 3-(GP IIb IIIa) tyrosine phosphorylation induced by platelet aggregation. J Biol Chem (1996) 1.70

Control of the translational regulators PHAS-I and PHAS-II by insulin and cAMP in 3T3-L1 adipocytes. J Biol Chem (1996) 1.69

Src-homology 3 domain of protein kinase p59fyn mediates binding to phosphatidylinositol 3-kinase in T cells. Proc Natl Acad Sci U S A (1993) 1.62

Immunological defects in mice with a targeted disruption in Bcl-3. Genes Dev (1997) 1.60

Role of platelets in thrombosis and hemostasis. Can J Physiol Pharmacol (1994) 1.58

Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity (1997) 1.56

Characterization of a functional thrombin receptor. Issues and opportunities. J Clin Invest (1992) 1.54

Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases. Curr Biol (1996) 1.42

Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo. Mol Cell Biol (1996) 1.24

Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro. FEBS Lett (1995) 1.22

Regulation of protein tyrosine kinases in platelets. Trends Biochem Sci (1994) 1.15

Expression of p60fyn in human platelets. Oncogene (1990) 1.15

Chemokine and chemokine receptor mRNA expression in human platelets. Cytokine (1995) 1.10

Translation. Turned on by insulin. Nature (1994) 1.07

Bcl-3-mediated nuclear regulation of the NF-kappa B trans-activating factor. Immunol Today (1994) 1.04

Human platelets contain mRNA transcripts for platelet factor 4 and actin. Thromb Haemost (1989) 0.91

De novo synthesis of DNA in human platelets. Arch Biochem Biophys (1983) 0.88

Stable messenger RNA in the synthesis of contractile protein in human platelets. Biochim Biophys Acta (1967) 0.87

The interaction of leukocytes with platelets in blood coagulation. Curr Opin Hematol (1995) 0.86

Platelet adhesion. Br J Haematol (1990) 0.85

Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets. FEBS Lett (1996) 0.83

Articles by these authors

Biochemistry of homologous recombination in Escherichia coli. Microbiol Rev (1994) 9.93

Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood (1998) 7.70

Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature (1990) 5.17

Platelet-activating factor and related lipid mediators. Annu Rev Biochem (2000) 3.44

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest (1995) 3.14

Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today (1992) 3.06

Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol (1991) 3.05

Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest (2001) 3.01

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature (1995) 2.79

Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol (2001) 2.75

Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem (1993) 2.61

Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol (1991) 2.59

Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest (1985) 2.58

Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest (1996) 2.51

Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med (1992) 2.47

Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci U S A (1984) 2.28

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest (1996) 2.21

Protein kinase C regulates the nuclear localization of diacylglycerol kinase-zeta. Nature (1998) 2.20

Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci U S A (1986) 2.18

Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest (1985) 2.16

Platelet-activating factor. J Biol Chem (1990) 2.13

Neutrophil adherence to human endothelium in vitro occurs by CDw18 (Mo1, MAC-1/LFA-1/GP 150,95) glycoprotein-dependent and -independent mechanisms. J Clin Invest (1988) 2.12

Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest (1995) 2.06

Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region. J Biol Chem (2000) 2.05

Catalysis research of relevance to carbon management: progress, challenges, and opportunities. Chem Rev (2001) 1.99

Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. J Biol Chem (1987) 1.93

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci U S A (1996) 1.88

Inflammatory roles of P-selectin. J Clin Invest (1993) 1.87

Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J Clin Invest (1997) 1.87

Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J Biol Chem (2001) 1.86

Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci U S A (2000) 1.85

Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol (1990) 1.84

Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J Biol Chem (2000) 1.77

Mammalian diacylglycerol kinases, a family of lipid kinases with signaling functions. J Biol Chem (1999) 1.73

Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates. J Biol Chem (1991) 1.71

Complications of pulmonary artery catheterization in the care of critically ill patients. A prospective study. Chest (1979) 1.68

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest (1995) 1.66

The leukocyte integrins. J Biol Chem (2000) 1.65

Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med (1998) 1.65

Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate. J Biol Chem (1983) 1.59

Human plasma platelet-activating factor acetylhydrolase. Purification and properties. J Biol Chem (1987) 1.55

The evolving role of platelets in inflammation. J Thromb Haemost (2003) 1.55

Platelet-activating factor acetylhydrolases. J Biol Chem (1997) 1.51

Diacylglycerol kinase epsilon regulates seizure susceptibility and long-term potentiation through arachidonoyl- inositol lipid signaling. Proc Natl Acad Sci U S A (2001) 1.51